ID

33164

Description

Regulation of Tissue Lipolysis by Insulin in Type 2 Diabetes; ODM derived from: https://clinicaltrials.gov/show/NCT01680133

Link

https://clinicaltrials.gov/show/NCT01680133

Keywords

  1. 11/30/18 11/30/18 -
Copyright Holder

See clinicaltrials.gov

Uploaded on

November 30, 2018

DOI

To request one please log in.

License

Creative Commons BY 4.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Type 2 Diabetes NCT01680133

Eligibility Type 2 Diabetes NCT01680133

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
caucasian
Description

Caucasian

Data type

boolean

Alias
UMLS CUI [1]
C0043157
normal blood pressure (sbp 100-140 mmhg, dbp 60-90 mmhg)
Description

Normal blood pressure | Systolic Pressure | Diastolic blood pressure

Data type

boolean

Alias
UMLS CUI [1]
C2712122
UMLS CUI [2]
C0871470
UMLS CUI [3]
C0428883
weight stable in last 3 months
Description

Stable body weight

Data type

boolean

Alias
UMLS CUI [1]
C0517386
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
smokers
Description

Tobacco use

Data type

boolean

Alias
UMLS CUI [1]
C0543414
people with intensive fitness training (e.g. athletes > 3 times/week)
Description

Physical fitness training With intensity

Data type

boolean

Alias
UMLS CUI [1,1]
C1535955
UMLS CUI [1,2]
C0522510
history of cardiovascular diseases
Description

Cardiovascular Diseases

Data type

boolean

Alias
UMLS CUI [1]
C0007222
bleeding disorders
Description

Blood Coagulation Disorders

Data type

boolean

Alias
UMLS CUI [1]
C0005779
use of medication interfering with the study endpoints/hypotheses (e.g. beta-blockers)
Description

Pharmaceutical Preparations Interfere with End Point | Pharmaceutical Preparations Interfere with Clinical Trial Hypothesis | Adrenergic beta-1 Receptor Antagonists

Data type

boolean

Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C0521102
UMLS CUI [1,3]
C2349179
UMLS CUI [2,1]
C0013227
UMLS CUI [2,2]
C0521102
UMLS CUI [2,3]
C0008976
UMLS CUI [2,4]
C1512571
UMLS CUI [3]
C0304516
not to be able to understand the study information
Description

Study Protocol Comprehension Unable

Data type

boolean

Alias
UMLS CUI [1,1]
C2348563
UMLS CUI [1,2]
C0162340
UMLS CUI [1,3]
C1299582
subjects on a special diet or vegetarian
Description

On special diet | Vegetarian

Data type

boolean

Alias
UMLS CUI [1]
C3164710
UMLS CUI [2]
C0042441
blood donation 2 months prior to the study and during the study
Description

Blood Donation

Data type

boolean

Alias
UMLS CUI [1]
C0005794
participating in an other study
Description

Study Subject Participation Status

Data type

boolean

Alias
UMLS CUI [1]
C2348568

Similar models

Eligibility Type 2 Diabetes NCT01680133

Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Caucasian
Item
caucasian
boolean
C0043157 (UMLS CUI [1])
Normal blood pressure | Systolic Pressure | Diastolic blood pressure
Item
normal blood pressure (sbp 100-140 mmhg, dbp 60-90 mmhg)
boolean
C2712122 (UMLS CUI [1])
C0871470 (UMLS CUI [2])
C0428883 (UMLS CUI [3])
Stable body weight
Item
weight stable in last 3 months
boolean
C0517386 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Tobacco use
Item
smokers
boolean
C0543414 (UMLS CUI [1])
Physical fitness training With intensity
Item
people with intensive fitness training (e.g. athletes > 3 times/week)
boolean
C1535955 (UMLS CUI [1,1])
C0522510 (UMLS CUI [1,2])
Cardiovascular Diseases
Item
history of cardiovascular diseases
boolean
C0007222 (UMLS CUI [1])
Blood Coagulation Disorders
Item
bleeding disorders
boolean
C0005779 (UMLS CUI [1])
Pharmaceutical Preparations Interfere with End Point | Pharmaceutical Preparations Interfere with Clinical Trial Hypothesis | Adrenergic beta-1 Receptor Antagonists
Item
use of medication interfering with the study endpoints/hypotheses (e.g. beta-blockers)
boolean
C0013227 (UMLS CUI [1,1])
C0521102 (UMLS CUI [1,2])
C2349179 (UMLS CUI [1,3])
C0013227 (UMLS CUI [2,1])
C0521102 (UMLS CUI [2,2])
C0008976 (UMLS CUI [2,3])
C1512571 (UMLS CUI [2,4])
C0304516 (UMLS CUI [3])
Study Protocol Comprehension Unable
Item
not to be able to understand the study information
boolean
C2348563 (UMLS CUI [1,1])
C0162340 (UMLS CUI [1,2])
C1299582 (UMLS CUI [1,3])
On special diet | Vegetarian
Item
subjects on a special diet or vegetarian
boolean
C3164710 (UMLS CUI [1])
C0042441 (UMLS CUI [2])
Blood Donation
Item
blood donation 2 months prior to the study and during the study
boolean
C0005794 (UMLS CUI [1])
Study Subject Participation Status
Item
participating in an other study
boolean
C2348568 (UMLS CUI [1])

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial